Obesity as an effect modifier of the risk of death in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 28, Issue SUPPL.4, 2013, Pages

  Kramer, Holly ^a   Dugas, Lara ^a   Shoham, David ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Effect modifier; ESRD; Mortality; Obesity

Indexed keywords

BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COST OF ILLNESS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MORTALITY; OBESITY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; WAIST HIP RATIO; WEIGHT REDUCTION;

EFFECT MODIFIER; ESRD; MORTALITY; OBESITY;

ADULT; HUMANS; OBESITY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVIVAL RATE;

EID: 84887108425     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft242     Document Type: Review

References (52)

1. Eknoyan G. A history of obesity, or how what was good became ugly and then bad. Adv Chronic Kidney Dis 2006; 13: 421-427
2. Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 2000; 72: 1074-1081
3. Anonymous Obesity: preventing and managing the global epidemic: report of a WHO consultation on obesity. World Health Organization, Geneva, June 3-5, 1997. 1998
4. Adams KF, Schatzkin A, Harris TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763-778
5. Fontaine KR, Redden DT, Wang C et al. Years of life lost due to obesity. JAMA 2003; 289: 187-193
6. Peeters A, Barendregt JJ, Willekens F et al. NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138: 24-32
7. Flegal KM, Kit BK, Orpana H et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71-82
8. Dyer AR, Stamler J, Garside DB et al. Long-term consequences of body mass index for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study. Ann Epidemiol 2004; 14: 101-108
9. Razak F, Anand SS, Shannon H et al. Defining obesity cut points in a multiethnic population. Circulation 2007; 115: 2111-2118
10. VanderWeele TJ. On the distinction between interaction and effect modification. Epidemiology 2009; 20: 863-871
11. Darroch J. Biologic synergism and parallelism. Am J Epidemiol 1997; 145: 661-668
12. Szklo M, Nieto JF. Epidemiology: Beyond the Basics. Gaithersburg, MD: Aspen Publisher, Inc., 2000
13. McGee DL, Diverse Populations C. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005; 15: 87-97
14. Ajani UA, Lotufo PA, Gaziano JM et al. Body mass index and mortality among US male physicians. Ann Epidemiol 2004; 14: 731-739
15. Johansen KL, Young B, Kaysen GA et al. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004; 80: 324-332
16. Leavey SF, McCullough K, Hecking E et al. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001; 16: 2386-2394
17. Kalantar-Zadeh K, Kuwae N, Wu DY et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 2006; 83: 202-210
18. Kovesdy CP, Czira ME, Rudas A et al. Body mass index, waist circumference and mortality in kidney transplant recipients. Am J Transplant 2010; 10: 2644-2651
19. Beddhu S, Allen-Brady K, Cheung AK et al. Impact of renal failure on the risk of myocardial infarction and death. Kidney Int 2002; 62: 1776-1783
20. Durward CM, Hartman TJ, Nickols-Richardson SM. All-cause mortality risk of metabolically healthy obese individuals in NHANES 3. J Obesity 2012; 2012: 12
21. Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97: 2482-2488
22. Flint AJ, Hu FB, Glynn RJ et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity 2010; 18: 377-383
23. Arnlov J, Ingelsson E, Sundstrom J et al. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121: 230-236
24. Bluher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 2012; 19: 341-346
25. Ikizler TA. Resolved: being fat is good for dialysis patients: the Godzilla effect: pro. J Am Soc Nephrol 2008; 19: 1059-1062
26. Beddhu S, Pappas LM, Ramkumar N et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14: 2366-2372
27. Beddhu S. The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial 2004; 17: 229-232
28. de Mutsert R, Snijder MB, van der Sman-de Beer F et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 2007; 18: 967-974
29. Kalantar-Zadeh K, Abbott KC, Salahudeen AK et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81: 543-554
30. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Philadelphia, PA: LippincottWilliams andWilkins, 2008
31. Elsayed EF, Sarnak MJ, Tighiouart H et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 2008; 52: 29-38
32. Hoogeveen EK, Halbesma N, Rothman KJ et al. Netherlands Cooperative Study on the Adequacy of Dialysis-2 (NECOSAD) Study Group. Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol 2012; 7: 280-288
33. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
34. Anonymous U S Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
35. Haneuse S, Schildcrout J, Crane P et al. Adjustment for selectionbias in observational studies with application to the analysis of autopsy data. Neuroepidemiology 2009; 32: 229-239
36. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann InternMed 2006; 144: 21-28
37. Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. Am J Physiol Renal Physiol 2008; 294: F685-F696
38. Lea J, Cheek D, Thornley-Brown D et al. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis 2008; 51: 732-740
39. Alves TP,Wang X,Wright JT, Jr et al. Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol 2010; 21: 1361-1369
40. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174
41. Kramer H, Reboussin D, Bertoni AG et al. Obesity and albuminuria among adults with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 2009; 32: 851-853
42. Postorino M, Marino C, Tripepi G et al. CREDIT (Calabria Registry of Dialysis and Transplantation) Working Group. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-1272
43. Kramer H, Shoham D, McClure LA et al. Association of waist circumference and body mass index with all-cause mortality in CKD: the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis 2011; 58: 177-185
44. Madero M, Sarnak MJ, Wang X et al. Body mass index and mortality in CKD. Am J Kidney Dis 2007; 50: 404-411
45. Kwan BC, Murtaugh MA, Beddhu S. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 992-998
46. Koster A, Leitzmann MF, Schatzkin A et al. Waist circumference and mortality. Am J Epidemiol 2008; 167: 1465-1475
47. Janssen I, Katzmarzyk PT, Ross R. Body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc 2005; 53: 2112-2118
48. Bigaard J, Tjonneland A, Thomsen BL et al.Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res 2003; 11: 895-903
49. Cordeiro AC, Qureshi AR, Stenvinkel P et al. Abdominal fat deposition is associated with increased inflammation, proteinenergy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant 2010; 25: 562-568
50. Zoccali C, Torino C, Tripepi G et al. Assessment of obesity in chronic kidney disease: what is the best measure? Curr Opin Nephrol Hypertens 2012; 21: 641-646
51. Anonymous clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. The National Institutes of Health. Obes Res 1998; 6: 51S-209S
52. LLG Financial Wealth Management and Planning. Raleigh, North Carolina. http://www.llgfinancial.com/overweight-obese.php. (25 March 2013, date last accessed)